DPIIT recognised startup Government of India
Startup India
Hyperion Biosciences Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹56.57 Lakh
▲ 95% YoY
Net loss · FY 2024
₹59.49 Lakh
Net margin -105.2%
EBITDA · FY 2024
-₹59.24 Lakh
EBITDA margin -104.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Hyperion Biosciences Private Limited
Data last updated:
Hyperion Biosciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 March 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC379357.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Kamath (Managing Director) and Sumana Kamath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 36 Ujagar Industrial Estate W T Patel Marg Deonar, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2024, the company reported a revenue of ₹56.57 Lakh, a growth of 95% compared to the previous year. For the same year it recorded a net loss of ₹59.49 Lakh (net margin -105.2%) and EBITDA of -₹59.24 Lakh (EBITDA margin -104.7%).
For more details, the company can be reached via its website tazohome.com.
Company Details of Hyperion Biosciences Private Limited
CIN U24290MH2022PTC379357
Registration Number 379357
Incorporation Date 29 March 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Hyperion Biosciences
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address36 Ujagar Industrial Estate W T Patel Marg Deonar, Mumbai, Maharashtra, India – 400088
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Hyperion Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Hyperion Biosciences Private Limited
The main business activity of Hyperion Biosciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hyperion Biosciences Private Limited FY 2025 filings available
Hyperion Biosciences Private Limited reported revenue of ₹56.57 Lakh (up 95% YoY) for FY 2024.
Revenue · FY 2024
₹56.57 Lakh ▲ 95%
Net loss · FY 2024
₹59.49 Lakh margin -105.2%
EBITDA · FY 2024
-₹59.24 Lakh margin -104.7%
Compounded Annual Growth Rate (CAGR) of Hyperion Biosciences Private Limited
Revenue CAGR growth
1 year
▲ 95%
EBITDA CAGR growth
1 year
▼ 81%
Revenue rose 95% in the latest year. EBITDA fell 81% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Hyperion Biosciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹59.24 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹59.49 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Hyperion Biosciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -104.7% | •••• | •••• |
| Net Profit Margin | -105.2% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hyperion Biosciences are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Hyperion Biosciences Private Limited
Hyperion Biosciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumana Kamath | Director | 29 Mar 2022 | 4 Years 6 Months | Current |
| Priyanka Kamath Also directs: Neel Sapphire Advisory LLP, Futura Biosystems Private Limited | Managing Director | 29 Mar 2022 | 4 Years 6 Months | Current |
Peer Comparison of Hyperion Biosciences Private Limited
Hyperion Biosciences Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biosciences). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avecure Biosciences Private Limited | ₹65.61 Lakh (FY 2023) | •••• | •••• | 164.0% | •••• | New Delhi, Delhi, India |
| Cellsys Biosciences Private Limited | ₹65 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Bestin Biosciences Private Limited | ₹60.74 Lakh (FY 2025) | •••• | •••• | -53.0% | •••• | Karnal, Haryana, India |
| Garphi Biosciences Private Limited | ₹58.87 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Hyderabad, Telangana, India |
| Providencia Biosciences Private Limited | ₹57.71 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Chennai, Tamil Nadu, India |
| Hyperion Biosciences Private Limited this company | ₹56.57 Lakh (FY 2024) | •••• | •••• | 95.0% | •••• | Mumbai, Maharashtra, India |
| Gifert Biosciences Private Limited | ₹56.54 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Bangalore, Karnataka, India |
| Avexza Biosciences Private Limited | ₹54.77 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Hyderabad, Telangana, India |
| Vivific Biosciences Private Limited | ₹54.11 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Thane, Maharashtra, India |
| Spe Biosciences Private Limited | ₹52.71 Lakh (FY 2025) | •••• | •••• | -93.0% | •••• | Mumbai, Maharashtra, India |
| Nanoarray Biosciences Private Limited | ₹51.95 Lakh (FY 2025) | •••• | •••• | 45469.0% | •••• | Valsad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Hyperion Biosciences by revenue in the Biotechnology industry (Biosciences), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Hyperion Biosciences Private Limited
Hyperion Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hyperion Biosciences Private Limited
Employment history and EPFO contributions of people linked to Hyperion Biosciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hyperion Biosciences Private Limited
Hyperion Biosciences Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Priyanka Kamath was appointed as Managing Director on 29 Mar 2022.
AGM
Hyperion Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hyperion Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Priyanka Kamath was appointed as Managing Director.
Appointed
Sumana Kamath was appointed as Director.
Incorporation
29 Mar 2022
Hyperion Biosciences Private Limited was registered on 29 Mar 2022 with Roc Mumbai I & aged 4 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Hyperion Biosciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hyperion Biosciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hyperion Biosciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hyperion Biosciences Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hyperion Biosciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hyperion Biosciences Private Limited
Hyperion Biosciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 March 2022 (4+ years old) and is registered under CIN U24290MH2022PTC379357.
Hyperion Biosciences reported revenue of ₹56.57 Lakh for FY 2024 (up 95% YoY).
Hyperion Biosciences has 2 current directors:
- Priyanka Kamath - Managing Director
- Sumana Kamath - Director
Hyperion Biosciences reported a net loss of ₹59.49 Lakh (net margin -105.2%) and EBITDA of -₹59.24 Lakh (EBITDA margin -104.7%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Hyperion Biosciences is U24290MH2022PTC379357. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyperion Biosciences was incorporated on 29 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Hyperion Biosciences by revenue are Avecure Biosciences Private Limited, Cellsys Biosciences Private Limited, Bestin Biosciences Private Limited, Garphi Biosciences Private Limited, Providencia Biosciences Private Limited and 5 more, all in the Biotechnology industry (Biosciences).
Priyanka Kamath was appointed as Managing Director on 29 Mar 2022. Sumana Kamath was appointed as Director on 29 Mar 2022.
Yes, Hyperion Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Hyperion Biosciences can be reached through the website tazohome.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Hyperion Biosciences is at 36 Ujagar Industrial Estate W T Patel Marg Deonar, Mumbai, Maharashtra, India – 400088.